Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
Oxford Endovascular has raised $10.2M in total funding. The most recent round was Series A. The last funding was announced in May 2024.
Oxford Endovascular's investors include Innovate UK, Parkwalk Advisors, Oxford Science Enterprises, University of Oxford, EASME.
Oxford Endovascular is headquartered in Oxford, United Kingdom.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
Oxford Endovascular is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oxford Endovascular — Funding & Investors." VCBacked, May 20, 2024, https://www.vcbacked.co/company/oxford-endovascular. Accessed July 19, 2026.
VCBacked. (2024). Oxford Endovascular — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/oxford-endovascular
{{cite web |title=Oxford Endovascular — Funding & Investors |url=https://www.vcbacked.co/company/oxford-endovascular |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated